Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local anesthetic with ketamine for mandibular posterior teeth with irreversible pulpitis
IRCT138905024440N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Dental School, Isfahan University of Medical Sciences
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine, ropivacaine in irreversible pulpitis, sponsored by Vice Chancellor for Research of Dental School, Isfahan University of Medical Sciences. Started Aug 2010; status: completed.
02
Drugs
ketamineropivacaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT138905024440N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138905024440N1.